Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5

Overview of attention for article published in BMC Cancer, October 2018

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

policy: 1 policy source

twitter: 2 X users

Citations

dimensions_citation: 17 Dimensions

Readers on

mendeley: 45 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 4,865 followers.

RT @Psbasran: Latest publication: Population-based phase II trial ofstereotactic ablative radiotherapy (SABR)for up to 5 oligometastases: S…

06 Oct 2018

Reply Repost Favourite

Latest publication: Population-based phase II trial ofstereotactic ablative radiotherapy (SABR)for up to 5 oligometastases: SABR-5 #medphys #radonc https://t.co/qdR5CPXszl

05 Oct 2018

Reply Repost Favourite